Desferrioxamine treatment of aceruloplasminemia: Long-term follow-up

Movement Disorders

Volumn 26, Issue 11, 2011, Pages 2142-2144

  Pan, Ping Lei ^a   Tang, He Han ^a   Chen, Qin ^a   Song, Wei ^a   Shang, Hui Fang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; DEFEROXAMINE; FERRITIN;

ACERULOPLASMINEMIA; ADULT; ANEMIA; ATAXIA; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CAUDATE NUCLEUS; DEGENERATIVE DISEASE; DEMENTIA; DENTATE NUCLEUS; DISEASE SEVERITY; DRUG EFFICACY; DYSTONIA; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GENE MUTATION; GLOBUS PALLIDUS; HAND TREMOR; HUMAN; IRON OVERLOAD; LETTER; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; RED NUCLEUS; RIGIDITY; SUBSTANTIA NIGRA; THALAMUS;

BRAIN; CERULOPLASMIN; DEFEROXAMINE; FEMALE; HUMANS; IRON METABOLISM DISORDERS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEURODEGENERATIVE DISEASES; SIDEROPHORES;

EID: 80052965448     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23797     Document Type: Letter

References (7)

1. Loreal O, Turlin B, Pigeon C, et al. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol. 2002; 36: 851-856.
2. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin JD. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol. 1997; 41: 404-407.
3. McNeill A, Pandolfo M, Kuhn J, Shang H, Miyajima H. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol. 2008; 60: 200-205.
4. Shang HF, Jiang XF, Burgunder JM, Chen Q, Zhou D. Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus. Mov Disord. 2006; 21: 2217-2220.
5. Grisoli M, Piperno A, Chiapparini L, Mariani R, Savoiardo M. MR imaging of cerebral cortical involvement in aceruloplasminemia. AJNR Am J Neuroradiol. 2005; 26: 657-661.
6. Kuhn J, Bewermeyer H, Miyajima H, Takahashi Y, Kuhn KF, Hoogenraad TU. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate. Brain Dev. 2007; 29: 450-453.
7. Chen Q, Chen XP, Zou L, et al. High brain iron level in asymptomatic carriers of heterozygous ceruloplasmin gene mutations. Mov Disord. 2008; 23: 916-917.